Unicycive Therapeutics In... (UNCY)
NASDAQ: UNCY
· Real-Time Price · USD
6.80
0.46 (7.26%)
At close: Jun 23, 2025, 12:27 PM
7.26% (1D)
| Bid | 6.78 |
| Market Cap | 819.82M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -15.2M |
| EPS (ttm) | -0.56 |
| PE Ratio (ttm) | -12.14 |
| Forward PE | 0.42 |
| Analyst | Buy |
| Ask | 7.21 |
| Volume | 1,374,926 |
| Avg. Volume (20D) | 342,205 |
| Open | 6.22 |
| Previous Close | 6.34 |
| Day's Range | 5.90 - 8.25 |
| 52-Week Range | 2.02 - 11.00 |
| Beta | 2.00 |
About UNCY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol UNCY
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for UNCY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 days ago
-8.89%
Unicycive Therapeutics shares are trading lower af...
Unlock content with
Pro Subscription
1 week ago
-40.89%
Unicycive Therapeutics shares are trading lower after the company announced update on its New Drug Application for oxylanthanum carbonate to treat hyperphosphatemia in patients with chronic kidney disease on dialysis.
